Universitätsklinikum Heidelberg

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: Clinical results and biomarker analysis of GeparNuevo study (2019) Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al. Journal article Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma (2019) Naoum C, Majenka P, Loquai C, Kaehler K, Heinzerling L, Dudda M, Hassel J Conference contribution Comparison of Pipeline Embolization Device and Flow Re-Direction Endoluminal Device Flow Diverters for Internal Carotid Artery Aneurysms: A Propensity Score-Matched Cohort Study (2019) Griessenauer CJ, Thomas AJ, Enriquez-Marulanda A, Deshmukh A, Jain A, Ogilvy CS, Kocer N, et al. Journal article NLRP6 Deficiency in CD4 T Cells Decreases T Cell Survival Associated with Increased Cell Death (2019) Radulovic K, Ayata CK, Mak'Anyengo R, Lechner K, Wuggenig P, Kaya B, Hruz P, et al. Journal article Impact of social support on psychosocial symptoms and quality of life in cancer patients: results of a multilevel model approach from a longitudinal multicenter study (2019) Sauer C, Weis J, Faller H, Junne F, Honig K, Bergelt C, Hornemann B, et al. Journal article High-risk multiple myeloma: Integrated clinical and omics approach dissects the neoplastic clone and the tumor microenvironment (2019) Solimando AG, Da Via MC, Cicco S, Leone P, Di Lernia G, Giannico D, Desantis V, et al. Journal article, Review article Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension (2019) Bringhen S, Milan A, D'Agostino M, Ferri C, Waesch R, Gay F, Larocca A, et al. Journal article